Advertisement

Search Results

Advertisement



Article Topics

Your search for all items matches 155 pages

Showing 201 - 200

Advertisement

Advertisement



May
29
Today In Oncology
Adjuvant Osimertinib Exceeds Expectations in EGFR-Positive NSCLC
Pembrolizumab Doubles Progression-Free Survival in MSI-H/dMMR Metastatic Colorectal Cancer
Maintenance Avelumab Improves Survival in Advanced Bladder Cancer
Continuous Coverage of COVID-19
Atezolizumab Alone or in Combination With Cobimetinib for Biliary Tract Cancer
View More 
Advertisement
Most Read Stories
Atezolizumab Plus Bevacizumab vs Sorafenib in Treatment-Naive Patients With Unresectable Hepatocellular Carcinoma
FDA Approves Sacituzumab Govitecan-hziy for Patients With Previously Treated Metastatic Triple-Negative Breast Cancer
Is Estrogen Protective Against COVID-19?
FDA Approves Nivolumab/Ipilimumab Plus Chemotherapy for First-Line Treatment of Metastatic or Recurrent NSCLC
FDA Approves Olaparib for HRR Gene–Mutated Metastatic Castration-Resistant Prostate Cancer
View More 
© 2020 HSP News Service, L.L.C.